|
|
Patient-Centric Care: Tailoring MASLD Management for Optimal Outcomes (Video and Simulation)
|
|
Facebook
LinkedIn
E-Mail
|
Released: 09/01/2024
Expires: 09/30/2025 (subject to change)
- CE for this activity will not be available after this date.
 | This activity includes closed captioning. |
Overview
The rates of metabolic syndrome and type 2 diabetes (T2D) are soaring to unprecedented heights in the US. Some estimates suggest that metabolic dysfunction-associated steatotic liver disease (MASLD) impacts a staggering ~30% of the global populace, and as its prevalence continues to climb, MASLD and its most severe manifestation – metabolic dysfunction-associated steatohepatitis (MASH) – is fast becoming one of the leading causes of liver-related morbidity, cirrhosis, and transplantation in the US.
Objectives - Describe the expanding clinical gravity of metabolic dysfunction-associated steatotic liver disease (MASLD) and characterize the need for streamlined evaluation, treatment, and referral pathways.
- Identify high-risk patients for metabolic dysfunction-associated steatotic liver disease (MASLD) based on risk factors.
- Utilize non-invasive diagnostic methods to diagnose and risk stratify patients with MASLD.
- Create a multidisciplinary care plan for patients with MASH in alignment with current treatment guidelines. (SIM objective)
Speakers
Kelly Casler, DNP, APRN-CNP, CHSE, EBP-C, FAANP
Amanda Chaney, DNP, APRN, FAANP, AF-AASLD
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.The speakers have the following disclosures: - Kelly Casler
- Advisory Board for Madrigal Pharmaceuticals
- Amanda Chaney
- Advisory Board on hepatic encephalopathy for Salix
- Faculty for GHAPP on topics of hepatology related topics
- Co-Chair of MASH Focus Group with Novo Nordisk
- Faculty for LLW Wolters Kluwer
- Author with Springer Publishing
All relevant financial relationships have been mitigated.All Planners involved in this activity have no relevant financial relationships to disclose.This educational activity is supported by an independent medical education grant from Novo Nordisk.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the educational content:
- Video Presentation:
- Complete the Pretest associated to the activity.
- Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button. Complete the post-test and evaluation to receive continuing education credit for this part of the activity.
- Simulation:
- Click the Play button to launch the simulation activity. This activity will open in a new window. Complete all parts of the simulation and close the window to return to your CE Activities list.
- After completing the simulation content, click on the blue Next Steps button. Complete the short evaluation to receive continuing education credit for this part of the activity.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.6 Contact Hour(s) of CE,
0.5 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
